Vaccines can't be made for some viruses. So, how confident is Merck CEO Ken Frazier that a vaccine could help eradicate Covid-19? 'There's strong confidence on the part of our scientists that we can get the vaccine,' he said.
Key Points
Most experts agree that it could take 12 to 18 months for a safe vaccine to be rolled out to the market. In a statement, Merck and IAVI said their vaccine candidate would use the recombinant vesicular stomatitis virus technology that is the basis for its Ebola Zaire virus vaccine — which was the first rVSV vaccine approved for use in humans.
If approved, Merck said both organizations would work together to develop the vaccine and "make it accessible and affordable" worldwide.it was important that, when a vaccine is ready, it could be equitably distributed across the globe.'Operation Warp Speed'has voiced ambitions for a vaccine to be developed and distributed by the end of 2020, in a project called "Operation Warp Speed.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Merck to buy Austrian vaccine maker as it jumps into COVID-19 raceMerck & Co Inc , which has largely kept to the sidelines of the race for COVID-19 treatments, said it was buying Austrian vaccine maker Themis Bioscience and would collaborate with research nonprofit IAVI to develop two separate vaccines.
Read more »
Merck Jumps Into The Race For A Coronavirus VaccineNew Jersey-based pharmaceutical Merck is undertaking 3 endeavors to fight Covid-19— including teaming up with nonprofit scientific research firm IAVI to develop a vaccine by lisettevoytko
Read more »
Merck in collaboration to develop a coronavirus vaccine, with clinical trials to start later this yearMost experts agree that it could take between 12 to 18 months for a safe-to-use vaccine to be rolled out to the market.
Read more »
Merck in collaboration to develop a coronavirus vaccine, with clinical trials to start later this yearMost experts agree that it could take between 12 to 18 months for a safe-to-use vaccine to be rolled out to the market.
Read more »
Novavax starts Phase 1 clinical trial of coronavirus vaccine candidateNovavax Inc said on Monday it has started the Phase 1 clinical trial of a novel coronavirus vaccine candidate and has enrolled the trial's first participants, with preliminary results slated for July.
Read more »
Merck to buy Austrian vaccine maker as it jumps into COVID-19 raceMerck & Co Inc , which has largely kept to the sidelines of the race for COVID-19 treatments, said it was buying Austrian vaccine maker Themis Bioscience and would collaborate with research nonprofit IAVI to develop two separate vaccines.
Read more »